Chad M. House
Cardiology Research Project Manager
About

Chad’s primary research interests are valvular heart disease and cardiac imaging. Prior to joining HealthPartners and Regions Hospital, Chad was a technical consultant in the heart valve division at Medtronic. While at Medtronic, Chad was involved with an original research project involving  prosthetic heart valve imaging artifacts, which stimulated his interest in clinical cardiology research. Since 2008 Chad and the cardiology investigators at Regions Hospital have more than 25 peer-reviewed publications.

Conducting Institute research since 2008.

Education and training:
Bachelor of Science; University of Minnesota-Duluth
Registered Diagnostic Cardiac Sonographer (RDCS)
Fellow of the American Society of Echocardiography (FASE)

Research interests include: Valvular heart disease and cardiac imaging

Current research activities and funding:
Evaluating sex differences in the quantification of mitral insufficiency using magnetic resonance imaging (MRI).

Related websites: Chad M House (researchgate.net)
Publications While At HealthPartners
selected publications
Journal Article
  • Gender differences in primary mitral regurgitant volumes at specific regurgitant fractions as assessed by magnetic resonance imaging. 
    International Journal of Cardiovascular Imaging. 2022
  • Inappropriate noise detection in Tendril family pacing leads. 
    Journal of Cardiovascular Electrophysiology. 2019
  • Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death. 
    Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology. 2017
  • Prevalence and doppler echocardiographic characteristics of normally functioning mitral prostheses with mean gradient >/=10 mmHg. 
    Journal of Heart Valve Disease. 2017
  • Safety of continuing warfarin therapy in patients undergoing cardiac resynchronization therapy device implantation
    2017
  • Feasibility of an elective cardioversion service led by advanced practice providers without direct cardiologist supervision
    2016
  • Normalization of left ventricular ejection fraction and incidence of appropriate antitachycardia therapy in patients with implantable cardioverter defibrillator for primary prevention of sudden death. 
    Journal of Cardiac Failure. 2016
  • The association between cardiac rehabilitation attendance and hospital readmission. 
    American Journal of Lifestyle Medicine. 2016
  • Anatomic versus effective orifice area in a bicuspid aortic valve. 
    Echocardiography (Mount Kisco, N.Y.). 2014
  • Letter by House et al regarding article, "Prosthesis-patient mismatch in bovine pericardial aortic valves: evaluation using 3 different modalities and associated medium-term outcomes". 
    Circulation: Cardiovascular Imaging. 2014
  • Reply to comment on: "Anatomic versus effective orifice area in a bicuspid aortic valve". 
    Echocardiography (Mount Kisco, N.Y.). 2014
  • Ultra low-dose single photon emission computed tomography myocardial perfusion imaging
    2014
  • Aortic pseudoaneurysm in a patient with rheumatoid arthritis. 
    Texas Heart Institute Journal. 2011
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients. 
    European Journal of Echocardiography. 2011
  • Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation. 
    Journal of Interventional Cardiac Electrophysiology. 2010
  • Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. 
    Heart rhythm. 2010
  • Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. 
    Heart International. 2010
  • Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation. 
    BMJ Case Reports. 2009
  • How reliable is an effective orifice area indexed chart?. 
    Journal of Heart Valve Disease. 2009
  • Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). 
    Journal of Cardiothoracic Surgery. 2009
  • Sudden cardiac arrest in apical hypertrophic cardiomyopathy. 
    BMJ Case Reports. 2009
    • Editorial Article
  • Questions regarding a recent study comparing mitral regurgitant volume between proximal flow convergence and volumetric methods: the importance of sex differences [editorial]. 
    Journal of the American Society of Echocardiography.  35. 2022
    • Review
  • Performing accurate standard 12 lead ECGs on patients with burns to the chest [review]. 
    Air Medical Journal. 2024
  • Manufacturer-provided effective orifice area index charts and the prevention of prosthesis-patient mismatch [review]. 
    Journal of Heart Valve Disease. 2012
  • Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a meta-analysis [review, meta-analysis]. 
    Interventional Cardiology. 2011
    • Abstract
  • A comparison of left ventricular volumes and ejection fraction by various commercially-available nuclear cardiology software on a CZT SPECT camera [abstract]. 
    Journal of Nuclear Cardiology. 2017
  • Management of functional Sprint Fidelis implantable cardioverter-defibrillator leads at cardiac resynchronization therapy-defibrillator generator replacement: an alternative approach for prevention of inappropriate shocks caused by lead failure [abstract]. 
    Journal of the American College of Cardiology. 2016
  • The incidence and doppler echocardiographic characteristics of normally functioning mitral prostheses with mean gradient ≥ 10 mm Hg [abstract]. 
    Journal of the American Society of Echocardiography. 2016
  • Early discharge with next day stress testing in low risk chest pain patients presenting to the emergency department is feasible [abstract]. 
    Annals of Emergency Medicine. 2015
  • Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death [abstract]. 
    Circulation. 2013
  • Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death [abstract]
    2013
  • High incidence of externalized conductors in St. Jude Medical Riata defibrillator leads: results of fluoroscopic surveillance from a single center in U.S. [abstract]. 
    Heart rhythm. 2012
  • The safety and efficacy of elective direct current cardioversion of atrial fibrillation and atrial flutter performed by advance practice providers [abstract]. 
    Heart rhythm. 2012
  • Ultra-low dose single photon emission computed tomography myocardial perfusion imaging [abstract]. 
    Journal of Nuclear Cardiology. 2012
  • Chronic kidney disease is a significant risk factor of pocket hematoma formation after pacemaker and implantable cardioverter-defibrillator placement independent of anticoagulation and antiplatelet agents [abstract]. 
    Journal of the American College of Cardiology. 2010
  • Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [abstract]. 
    Heart rhythm. 2010
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients [abstract]. 
    Journal of the American Society of Echocardiography. 2010
  • Continuation of warfarin is superior to holding warfarin with or without bridging therapy in patients undergoing pacemaker and defibrillator placement [abstract]. 
    Circulation. 2009
  • Safety of cardiac resynchronization therapy device implantation in patients with uninterrupted chronic warfarin therapy [abstract]. 
    Circulation. 2009
    • presentations
    Presentation
  • A comparison of three different peri-operative anticoagulation strategies during cardiac resynchronization therapy implantation [presentation]
  • Association and severity of coronary artery disease and carotid artery disease in patients with aortic stenosis [presentation]
  • Chronic kidney disease is a significant predictor of pocket hematoma complications after pacemaker and implantable cardioverter defibrillator placement independent of anticoagulation and antiplatelet agents [presentation]
  • Continuation of warfarin is superior to holding warfarin with or without bridging therapy in patients undergoing pacemaker and defibrillator placement [presentation]
  • How reliable is an effective orifice area indexed chart [presentation]?
  • Management of functional Sprint Fidelis implantable cardioverter-defibrillator leads at cardiac resynchronization therapy-defibrillator generator replacement: an alternative approach for prevention of inappropriate shocks caused by lead failure [presentation]
  • Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [presentation]
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients [presentation]
  • Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death [presentation]
  • Predictors and prognosis of worsening renal function in patients hospitalized with acute diastolic heart failure and treated with intravenous furosemide [presentation]
  • Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB) [presentation]
  • Safety of cardiac resynchronization therapy device implantation in patients with uninterrupted chronic warfarin therapy [presentation]
  • Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a systematic review and meta-analysis [presentation]
  • The assessment of cardiac workload during simulated firefighting tasks [presentation]
  • The dose response of cardiac rehabilitation [presentation]
  • The implementation of cognitive function assessment during cardiac rehabilitation [presentation]
  • The incidence and doppler echocardiographic characteristics of normally functioning mitral prostheses with mean gradient ≥ 10 mm Hg [presentation]
  • The safety and efficacy of elective direct current cardioversion of atrial fibrillation and atrial flutter performed by advance practice providers [presentation]
  • Ultra-low dose single photon emission computed tomography myocardial perfusion imaging [presentation]
    • Contact
    full name
  • Chad M. House
    • primary email
  • Chad.M.House@HealthPartners.com
    • phone
  • 651-254-3485
    • Quick Info
     
    Collaboration
    Contact Information